NEW YORK – Which stories were GenomeWeb's readers most interested in last week? Here are the top five:
- Grail Projects Future After Illumina, May Present Trial Data to NHS This Summer
- Singular Genomics Q1 Revenues Fall 49 Percent
- Researchers Turn Illumina's NovaSeq 6000 Into Spatial Transcriptomics Instrument
- FDA Warns Against Use of Cue Health COVID-19 Tests
- New Biosecure Act Draft Proposes 2032 Deadline to Cease Activities with BGI, MGI, Affiliates